The Biden administration’s messy response to getting the pandemic under control doesn’t merely apply to there not being enough rapid tests, but to treatments as well. On Wednesday, Rep. Chip Roy (R-TX) sent a letter to Health & Human Services Secretary Xavier Becerra inquiring about monoclonal antibody treatments (mAb), especially since those like the Sotrovimab are “running dry” in Texas.
The Sotrovimab treatment appears to be the only one working with patients with the Omicron variant. As the letter quotes, the Sotrovimab website warns on the home page that “GSK has entered into a contract with the U.S. government to purchase sotrovimab. Sotrovimab is not available for commercial purchase at this time. More details of government directed distribution will be provided in the coming weeks.”